UnitedHealth Group Incorporated (UNH Quick QuoteUNH ) stands well-poised for growth on the back of robust top-line growth, strong presence amid Medicare and Medicaid markets, and a solid financial position. An upbeat 2021 EPS guidance reinstates the growth prospects for the stock.
Zacks Rank & Price Performance
Presently, UnitedHealth Group carries a Zacks Rank #3 (Hold). You can see the complete list of today’s Zacks #1 Rank (Strong Buy) stocks here.
The stock has gained 31.7% over a year compared with the industry’s rally of 23.2%. However, the Zacks Medical sector has lost 2.8% in the said time frame.
Image Source: Zacks Investment Research
The company is well-poised for progress as evident from its impressive VGM Score of A. Here V stands for Value, G for Growth and M for Momentum, with the score being a weighted combination of all three factors.
Top 10 Medical Stocks For 2022: Bazaarvoice, Inc.(BV)
Bazaarvoice, Inc., incorporated on May 25, 2005, offers solutions and services that allow its retailer and brand clients to understand that consumer voice and the role it plays in influencing purchasing decisions, both online and offline. The Company’s solutions collect, curate and display consumer-generated content, including ratings and reviews, questions and answers, customer stories, and social posts, photos and videos. This content is syndicated and distributed across its clients’ marketing channels, including category/product pages, search terms, brand sites, mobile applications, in-store displays, and paid and earned advertising. Its solutions, which it provides primarily through a software-as-a-service (SaaS) platform, enable the clients to capture and display consumer-generated content, such as online ratings and reviews, photos, and questions and answers about specific products and services; syndicate that consumer-generated content into its network of brand and retail clients; understand consumer behavior, and monetize the value of that content through targeted advertising based on online and offline shopping behavior.
The Company’s geographical segments include Americas, EMEA and Other. Its solutions operate in two categories of products and services: the collection, curation, growth and analysis of consumer-generated content, and the distribution and monetization of consumer-generated content collected by its clients. The collection, Curation, Growth and Analysis of Consumer-Generated Content category includes Bazaarvoice Conversations Platform, Bazaarvoice Curations, Bazaarvoice Product Sampling and Bazaarvoice Spotlights. The distribution and monetization of consumer-generated content collected by its client’s category includes Bazaarvoice Connections Solutions, Bazaarvoice Advertising and Bazaarvoice Professional and Managed Services.
Bazaarvoice Conversations Platform
The Conversations platform provides its retailer and brand clients with capabil! ities to capture, manage and display online consumer-generated content. Consumers interact with the Company’s solutions as they view or author consumer reviews, questions, photos, videos, long-format narratives and other forms of consumer-generated content. Content that is displayed by the Company’s Conversations platform can be styled to match its clients’ brand, preserving branding elements of its clients’ businesses. Content collected and managed by the Company’s Conversations platform is used by its clients in a range of applications, including their online Websites, mobile-optimized Websites, mobile applications, social networks, in-store kiosks, physical in-store displays, printed flyers, e-mail, and other forms of online and offline media. The key products and features of the Conversations platform include ratings and reviews, questions and answers, seller ratings and workbench analytics. The ratings and reviews allow its clients to capture, manage and display consumer reviews about their products and services on their Websites and mobile-optimized Websites. The questions and answers allow its clients to facilitate question and answer conversations between consumers, or between consumers and brand representatives, on their Websites. The seller ratings provide clients the ability to solicit and collect reviews about their company. Seller ratings are based on reviews about customers’ online experiences with the client’s company.
The Bazaarvoice Curations allow the Company’s clients to pull in content from across a range of social platforms, including Instagram, Facebook and Twitter. Clients can then organize and display photos, videos, text and links that leverage social content throughout their site.
Bazaarvoice Product Sampling
The Bazaarvoice Product Sampling allows brands and retailers to build their own branded community. The Bazaarvoice Product Sampling helps in engaging their advocates to gain content and momentum for ! new produ! cts, seasonal launches or across a portfolio.
The Bazaarvoice Spotlights provides its clients the opportunity to achieve search results at the product category level. This is done by including consumer-generated content on their category pages, in addition to their product pages.
Bazaarvoice Connections Solutions
The Conversations clients are connected through its SaaS platform to form a syndication network. It offers network syndication and brand engagement solutions to facilitate the distribution of online consumer generated content among its clients, and to enable brands to directly interact with consumers on its retail clients’ Websites. Its BrandAnswers enables brands to interact directly with consumers on retail Websites within its network to answer questions and provide suggestions on alternative products. The Company’s Review Response enables brands to interact with consumers by responding to reviews posted on retail Websites within its network.
By leveraging shopper devices in the Company’s network, the advertising platform enables its brands and retailers to place digital advertising directly to in-market shoppers, based on their behavior in reading reviews, interacting with product data pages and searching category pages. The key products and features of its Advertising platform include Shopper Segments, Word of Mouth Advertisements, Mobile Advertising and Retail Site Monetization. It develops shopper profiles and sells targeted sets of shoppers to brand marketing departments, shopper marketing agencies and media agencies. The Company also sells to non-retail brands, such as those within the automotive and financial industries that wish to reach the engaged shopper. Its Advertising solution enables brands to reach consumers on their mobile devices.
The Company competes with PowerReviews, Sprnklr, Turn To, Reevoo, eKomi, Yotpo, Rating System and Gigya.
- [By Motley Fool Transcribers]
BrightView Holdings Inc (NYSE:BV)Q12019 Earnings Conference CallFeb. 07, 2019, 10:00 a.m. ET
Prepared Remarks Questions and Answers Call Participants
- [By Paul Ausick]
BrightView Holdings Inc. (NYSE: BV) raised $469 million selling 21.3 million shares at $22, the low end of the expected range. Shares dropped 3% on the first day of trading and closed the week flat.
- [By Paul Ausick]
Below is Renaissance Capital’s list of the second quarter’s 10 largest IPOs ranked by deal size. We’ve also included the stock’s first-day pop (or decline) and its return as of the most recent close. Spotify Technology S.A. (NYSE: SPOT) is not included because its IPO was a direct offering that did not raise any new cash. Spotify shares popped nearly 13% on the April offering date, and the return to date is 27%.
AXA Equitable Holdings Inc. (NYSE: EQH): $2.75 billion; first-day pop of 1.7%; return to date: 1.3% GreenSky LLC (NASDAQ: GSKY): $874 million: pop of 1.6%; return of 7.9% BJ’s Wholesale Club Holdings Inc. (NYSE: BJ): $638 million; pop and return of 29.4% DocuSign Inc. (NASDAQ: DOCU): $629 million; pop of 37.0%; return of 83.0% Pivotal Software Inc. (NYSE: PVTL): $555 million; pop of 5.0%; return of 71.0% GrafTech International Ltd. (NYSE: EAF): $525 million; decline of 3.7%; return of 23.0% BrightView Holdings Inc. (NYSE: BV): $469 million; decline of 2.7%; return of 2.7% Ceridian HCM Holding Inc. (NYSE: CDAY): $462 million; pop of 42.0%; return of 55.0% Essential Properties Realty Trust Inc. (NYSE: EPRT): $455 million; decline of 2.6%; return of 3.6% PluralSight Inc. (NASDAQ: PS): $311 million; pop of 33.0%; return of 61.0%
Looking ahead to the third quarter, Renaissance Capital notes 65 companies currently in the IPO pipeline looking to raise $11 billion. Real estate firm Cushman & Wakefield is the both the largest potential IPO ($500 million) and the largest based on trailing 12-month sales ($7.23 billion). The pipeline is again heavy on health care offerings (11), industrials (five), financials (five) and, in a bit of a comeback, energy (four).
Top 10 Medical Stocks For 2022: Extra Space Storage Inc(EXR)
Extra Space Storage, Inc. operates as a real estate investment trust (REIT) in the United States. It engages in property management and development activities that include acquiring, managing, developing, and selling, as well as the rental of self-storage facilities. As of December 31, 2006, Extra Space Storage owned interests in 567 properties located in 32 states and Washington, D.C., as well as managed 74 properties owned by franchisees or third parties. As a REIT, the company would not be subject to federal corporate income taxes if it distributes at least 90% of its taxable income to its stockholders. The company was founded in 1977 and is based in Salt Lake City, Utah.
- [By Max Byerly]
Here are some of the headlines that may have impacted Accern Sentiment Analysis’s rankings:
Get Oncomed Pharmaceuticals alerts:
Recent Technicals: OncoMed Pharmaceuticals (NASDAQ: OMED) (reagentsglobalmarket.com) OncoMed Pharmaceuticals, Inc. (NasdaqGS:OMED) Book to Market Valuation Stands at 0.479899 (vassarnews.com) Zacks: Analysts Expect Oncomed Pharmaceuticals Inc (OMED) Will Announce Quarterly Sales of $7.97 Million (americanbankingnews.com) Oncomed Pharmaceuticals Inc (OMED) Expected to Post Earnings of -$0.20 Per Share (americanbankingnews.com) Oncomed Pharmaceuticals Inc (OMED) Receives Average Rating of “Hold” from Analysts (americanbankingnews.com)
Several brokerages have weighed in on OMED. Zacks Investment Research cut shares of Oncomed Pharmaceuticals from a “buy” rating to a “hold” rating in a research note on Tuesday, August 21st. ValuEngine raised shares of Oncomed Pharmaceuticals from a “strong sell” rating to a “sell” rating in a research note on Wednesday, May 2nd. Five research analysts have rated the stock with a hold rating and one has assigned a buy rating to the stock. The company currently has a consensus rating of “Hold” and an average price target of $4.30.
Top 10 Medical Stocks For 2022: Ternium S.A.(TX)
Ternium S.A. manufactures and processes various steel products in Mexico, Argentina, Bolivia, Chile, Paraguay, Uruguay, the United States, Central America, Colombia, and internationally. It operates through two segments, Steel and Mining. The Steel segment offers steel products, such as slabs, billets and round bars, hot-rolled coils and sheets, bars and stirrups, wire rods, cold-rolled coils and sheets, tin plates, hot dipped galvanized and electrogalvanized sheets, pre-painted sheets, steel pipes and tubular products, beams, and roll formed products, as well as pre-engineered metal building systems. The Mining segment sells iron ore concentrates and pellets. The company serves various companies and small businesses that are operating in the construction, automotive, home appliances, capital goods, container, food, and energy industries. The company was founded in 1961 and is headquartered in Buenos Aires, Argentina. Ternium S.A. is a subsidiary of San Faustin S.A.